- Why Work With NSF?
NSF Pharma Biotech has helped companies that have been placed on import alert and have had their products subject to detention without physical examination (DWPE). We can determine what conditions are causing the import alert and assist your company with the remediation of these conditions. In addition, we can interface with the agency with your approval to help better understand the actions required to lift the import alert.
For more information about NSF Pharma Biotech regulatory enforcement action support in the U.S., email email@example.com or call +1 202.822.1850.
For more information about NSF Pharma Biotech regulatory enforcement action support in Europe, email firstname.lastname@example.org or call +44 1751 432 999.
Why Work With NSF?
Our team includes former U.S. FDA inspectors and experts who have a proven track record for addressing the most complex regulatory problems and compliance issues. We can interface with the agency on your behalf to help you to better understand the actions needed to lift the import ban.
- 4 months ago
FDA Regulatory and Compliance News FDA announced the availability of a draft guidance for industry and FDA staff entitled, “Public...
- 4 months ago
FDA Regulatory and Compliance News FDA announced the approval of Torax Medical’s Fenix Continence Restoration System to treat fecal incontinence...
- 6 months ago
ANN ARBOR, Mich. and ARLINGTON, Va. – NSF Health Sciences Certification, LLC (NSF), which provides testing, auditing, certification and training...
- Wednesday, April 20, 2016
- 8:30am - 12:00pm Pacific Time
- San Diego, California, United States
- Thursday, May 5, 2016
- 1:00pm - 1:30pm GMT
- Webinar, United Kingdom
- Monday, May 9, 2016
- 8:30am - 3:00pm GMT
- Glasgow, United Kingdom
- Monday, May 16, 2016
- 8:30am - 5:00pm GMT
- Manchester, United Kingdom